Magnetic resonance imaging-targeted biopsy with index lesion ipsilateral or bilateral systematic biopsy in prostate cancer: A multicenter, paired, noninferiority, observational trial.

Saved in:
Bibliographic Details
Title: Magnetic resonance imaging-targeted biopsy with index lesion ipsilateral or bilateral systematic biopsy in prostate cancer: A multicenter, paired, noninferiority, observational trial.
Authors: Cheng Y; Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.; Institute of Urology, Nanjing University, Nanjing, China., Huang H; Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.; Institute of Urology, Nanjing University, Nanjing, China., Wang M; Department of Urology, Beijing Hospital, National Center of Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Zhu L; Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China., Peng S; Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Li D; Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Marra G; Division of Urology, Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy., Qi R; Medical Statistics and Analysis Center, Nanjing Drum Tower Hospital, Nanjing, China., Ding X; Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China., Liu M; Department of Urology, Beijing Hospital, National Center of Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Qiu X; Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.; Institute of Urology, Nanjing University, Nanjing, China., Guo H; Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.; Institute of Urology, Nanjing University, Nanjing, China.
Source: Cancer [Cancer] 2026 Jul 01; Vol. 132 (13), pp. e70493.
Publication Type: Journal Article; Multicenter Study; Observational Study; Equivalence Trial
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-0142
DOI:10.1002/cncr.70493